CD109 and familial pancreatic carcinoma: Here, we report the generation of two mAbs, KU42.33C and KU43.13A, against two distinct epitopes on the external domain of CD109, using the human pancreatic cancer cell line BxPC-3 as the source of tumour immunogen.